Medicxi Ventures Management as of March 31, 2025
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 65.6 | $287M | 20M | 14.38 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 13.4 | $59M | 2.9M | 20.47 | |
| Phathom Pharmaceuticals (PHAT) | 10.7 | $47M | 7.5M | 6.27 | |
| Rapt Therapeutics | 6.2 | $27M | 22M | 1.22 | |
| Aura Biosciences (AURA) | 4.1 | $18M | 3.0M | 5.86 |
